Scrip
Novartis defends South Korean pricing of Glivec
05 February 2010
Ian Haydock
Novartis has rebutted suggestions that it has resisted attempts to reduce the cost of its leukaemia drug Glivec (imatinib) in South Korea.
Information released through the website of Ip-health, giving the Korean Leukaemia Patient Group as a contact, stated that it had been "a long and tedious...
Please Login to read the full article.
05 February 2010
Ian Haydock
Information released through the website of Ip-health, giving the Korean Leukaemia Patient Group as a contact, stated that it had been "a long and tedious...
Please Login to read the full article.
RELATED CONTENT
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
